Louis Moore Bacon's WST Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 95,000 shares of West Pharmaceutical Services, Inc. (WST) worth $24.92 M, representing 0.34% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 60,000 shares. Largest reduction occurred in Q3 2024, reducing 15,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +5,000 | New Buy | 5,000 | $346.47 |
| Q2 2023 | -5,000 | Sold Out | 5,000 | $0.00 |
| Q1 2024 | +65,000 | New Buy | 65,000 | $395.71 |
| Q2 2024 | +15,000 | Add 23.08% | 80,000 | $329.39 |
| Q3 2024 | -15,000 | Reduce 18.75% | 65,000 | $300.16 |
| Q4 2024 | -2,000 | Reduce 3.08% | 63,000 | $327.56 |
| Q1 2025 | -63,000 | Sold Out | 63,000 | $0.00 |
| Q3 2025 | +95,000 | New Buy | 95,000 | $262.33 |
Louis Moore Bacon's West Pharmaceutical Services Investment FAQs
Louis Moore Bacon first purchased West Pharmaceutical Services, Inc. (WST) in Q1 2023, acquiring 5,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held West Pharmaceutical Services, Inc. (WST) for 11 quarters since Q1 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q3 2025, adding 95,000 shares worth $24.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 95,000 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $24.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.34% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in West Pharmaceutical Services, Inc. (WST) was 95,000 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.